Notch3 Intracellular Domain Accumulates in Hepg2 Cell Line

Total Page:16

File Type:pdf, Size:1020Kb

Notch3 Intracellular Domain Accumulates in Hepg2 Cell Line ANTICANCER RESEARCH 26: 2123-2128 (2006) Notch3 Intracellular Domain Accumulates in HepG2 Cell Line CATIA GIOVANNINI1,2, MICHELA LACCHINI2, LAURA GRAMANTIERI1,2, PASQUALE CHIECO2 and LUIGI BOLONDI1,2 1Department of Internal Medicine and Gastroenterology, University of Bologna and S. Orsola-Malpighi University Hospital, 40138 Bologna; 2Center for Applied Biomedical Research (CRBA), S. Orsola-Malpighi University Hospital, 40138 Bologna, Italy Abstract. Background: By mediating local cell-cell epithelial growth factor repeats and a lin-12 Notch repeat interactions, the Notch signaling pathway seems to control a as well as a transmembrane subunit (NTM 97-120 kDa) variety of processes from cell fate decisions during containing a short extracellular fragment and an development, to stem cell renewal and to differentiation in intracellular domain (NICD 65-110 kDa) (1). These non- many adult tissues. Hence, perturbed Notch signaling may covalently associated subunits are presented as a be involved both in the development and the spread of heterodimeric functional receptor at the cell surface. Even cancer. The expression and the functional role of some though ligand-independent activation of the Notch major components of the Notch signaling pathway in signaling pathway has been described (2), Notch receptors human hepatocellular carcinoma (HCC) are poorly are mainly activated by transmembrane ligands expressed characterized. Materials and Methods: Notch3, HES1, on the surface of neighboring cells. Five ligands of Notch Jagged1 and Delta1 were analyzed both at the RNA and receptors have been described in vertebrates: Delta-like 1, protein levels in the HepG2 liver cell line derived from 3 and 4 and Jagged 1 and 2 (3, 4). Upon ligand binding to human HCC. Results: The results of this study the extracellular domain of Notch receptors, two demonstrated, for the first time, that both Jagged1 and sequential proteolytic events occur. First, cleavage takes Delta1 ligands and the downstream effector gene HES1 are place twelve amino acids outside the transmembrane expressed in the HepG2 actively proliferating cell line. domain by metalloproteinase TACE/ADAM17 (5). The Moreover, a high expression of Notch3 intracellular domain, resulting Notch COOH-terminal fragment, called NEXT indicative of constitutively activated Notch signaling, was (Notch extracellular truncation), is required for the second the only detectable Notch3 subunit in HepG2. Conclusion: cleavage performed by Á-secretase within the trans- These findings suggest that Notch3 may be involved in membrane region. This last proteolytic event releases the mechanisms controling the differentiation and the spread of Notch intracellular domain (NICD) into the cytoplasm (6). HCC and that Notch3 activation may be dependent on both The NICD translocates into the nucleus, binding to the Jagged1 and Delta1 ligands. transcription factor CBF1/RBP-Jk transactivating target genes. To date, the HES (hairy/enhancer of split) and Notch genes encode for a family of highly conserved HERP (HES-related repressor protein) families of single-pass transmembrane receptors known as Notch 1, 2, transcriptional repressors are the only known major targets 3 and 4. Notch receptors are synthesized as ~300 kDa of Notch signaling (7, 8). proteins (pro-Notch) which are then cleaved by a furin-like By mediating local cell-to-cell communication, the Notch convertase in the Golgi. This proteolytic event releases an family of receptors controls either cell fate and spread EC extracellular subunit (N ~200 kDa) containing many during development or stem cell renewal and differentiation in many adult tissues (9, 10). A perturbed Notch signaling pathway has been described in different human diseases, including cancer. Constitutively active Notch1 and Notch4 Correspondence to: Dr. Catia Giovannini, CRBA, Pad. 23, polypeptides were found to be involved in human acute S. Orsola-Malpighi University Hospital, Via Massarenti 9, 40138 T-lymphoblastic leukemia (T-ALL) and mouse mammary Bologna, Italy. Tel: +39-051-6364903, Fax: +39-051-6363902, e-mail: [email protected] tumor development, respectively (11, 12). The induced expression of constitutively active Notch4 has been Key Words: Notch3, Delta1, Jagged1, HES1, HCC. described to promote the expansion of hematopoietic stem 0250-7005/2006 $2.00+.40 2123 ANTICANCER RESEARCH 26: 2123-2128 (2006) Table I. Primer sequences for RT-PCR analysis. Gene Primer sequence Product Annealing size temp. ÆC Notch3 FW 5’-aaggacgtggcctctggt-3’ 91 62 REV 5’-tcaggctctcacccttgg-3’ Notch3 FW 5’-aaggacgtggcctctggt-3’ 2043 60.6 REV 5’-ggcccccaagatctaagaac Delta1 FW 5’-agcaagcgtgacaccaag-3’ 286 61 Figure 1. Notch3 gene expression evaluated by RT-PCR. A) Conventional REV 5’-tcctcttcagcagcattcg-3’ PCR performed with Herculase Taq Polymerase. B) Real-time PCR Jagged1 FW 5’-tcgctgtatctgtccacctg-3’ 227 64 products loaded on agarose gel. N.G.: PCR-negative control. REV 5’-agtcactggcacggttgtag-3’ HES1 FW 5’-gctggtgctgtctggatg-3’ 176 62 REV 5’-cattcctgctctcgccttc-3’ Fw, forward; Rev, reverse. cells in vitro (13). These observations suggest that unregulated NICD expression prevents differentiation, favoring malignant transformation. On the other hand, constitutive activation of Notch1 may function as a tumor suppressor in small cell lung cancer cells, in prostate cancer cells and in mouse skin (14-16) by inducing cell growth arrest. Epidemiological evidence indicates that human hepatocellular carcinoma (HCC) is one of the most prevalent neoplasms worldwide. The molecular mechanisms controlling the differentiation and the spread of HCC are still largely unknown. The Notch1 signaling pathway is activated during rat liver regeneration and overexpression of Notch1 has been found to inhibit the growth of HCC Figure 2. Whole-cell extracts (50 Ìg) of the HepG2 cell line were electrophoresed and immunoblotted with the indicated antibodies. A and cells in vitro and in vivo (17). Notch3 has recently been B in the upper panel designate the two different antibodies used against described to be involved in bile duct development (18) but, Notch3; A (BC4), B (sc-5593). to date, there are no studies concerning Notch3 expression and function in HCC. The aim of the present study was to investigate the expression of some major components of the Notch reaction mixture including: 1X RT buffer, 0.4 mM dNTPs, 5 mM signaling pathway, including Notch3, Jagged1, Delta1 and dithiothreitol (DTT), 0.5 ÌM oligodT, 3 ÌM random primers, 240 U Superscript II (all reagents from Invitrogen). The RT the downstream effector gene, HES1, in the HepG2 tumor reaction was carried out at 42ÆC for 1 h, followed by 5 min at 95ÆC cell line. to inactivate the enzyme. Hes1, Jagged1 and Delta1 gene expressions was assessed by real-time PCR using the iCycler Materials and Methods Thermal Cycler (Bio-Rad, Hercules, CA, USA). Notch3 gene expression was assessed using both real-time and conventional end- Cell lines. The HCC HepG2 cell line was obtained from the point PCR amplification. American Type Culture Collection (HB-8065, ATCC, Rockville, For real-time PCR, all transcripts were amplified in 25 Ìl of MD, USA) and was maintained in Eagle’s minimum essential reaction using 1 Ìl of cDNA, 300 mM of each primer and the iQ media (MEM) supplemented with 10% fetal bovine serum (FBS), SYBER Green Supermix (Bio-Rad). Standard curves were 100 U/ml penicillin and 100 mg/ml streptomycin (all reagents from generated by making appropriate dilutions of samples of cDNA ATCC) at 37ÆC in a 5% CO2 incubator. synthesized from human liver tissues. The real-time products were loaded on agarose gel to rule out aspecific amplifications. Reverse transcriptase-polymerase chain reaction (RT-PCR). RNA was Conventional PCR was performed with Herculase Taq Polymerase isolated from the HepG2 cell line by TRIzol (Invitrogen, Paisley, (Stratagene, La Jolla, CA, USA) as described by the company and Scotland), according to the manufacturer’s instructions. Four Ìg of the PCR product was resolved on 1% agarose gel containing total RNA were treated with DNAse I (Invitrogen) to eliminate ethidium bromide. The primer sequences and the annealing contaminating genome DNA. RT was performed in 30 Ìl of temperature are listed in Table I. 2124 Giovannini et al: Notch3 Expression in HepG2 Cell Line Figure 3. Expression and subcellular localization of the Notch3 receptor, as detected by the immunoperoxidase method, of the HepG2 cell line. Positive staining was observed in the cytoplasm and at the nuclear level. Nuclei were counterstained with hematoxylin. Original magnification 40X. Protein extraction. The cultured HepG2 cell line was dissolved in Immunocytochemistry. The HepG2 cells were seeded on sterilized lysis buffer containing 10 mM Tris-HCl pH 7.4, 2.5 mM MgCl2, 1% cover-slips and fixed in 4% paraformaldeyde. The cells were then TritonX 100, 1 mM DTT, 0.1mM phenylmethylsulfonyl fluoride permeabilized in PBS containing 0.1% of saponin and incubated with (PMSF) and protease inhibitors (Sigma Chemical Co., St. Louis, normal goat serum at room temperature for 30 min. Notch3 protein MO, USA). The lysate was then centrifuged at 4ÆC, 15,000 x g, for localization into the cell was assessed with the same antibody used in 15 min and the supernatant was assayed for the protein Western blot ( Santa Cruz), followed by an HRP-rabbit EnVision concentration using the Bio-Rad protein assay (Bio-Rad). system with Vector Red (Vector Laboratories, Burlingame, CA, USA) as chromogen. The cells were then counterstained
Recommended publications
  • Association of Notch and Hedgehog Pathway Activation with Prognosis
    ANTICANCER RESEARCH 39 : 2129-2138 (2019) doi:10.21873/anticanres.13326 Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer GRIGORIOS RALLIS 1, TRIANTAFYLLIA KOLETSA 2, ZENIA SARIDAKI 3, KYRIAKI MANOUSOU 4, GEORGIA-ANGELIKI KOLIOU 4, IOANNIS KOSTOPOULOS 2, VASSILIKI KOTOULA 2,5 , THOMAS MAKATSORIS 6, HELEN P. KOUREA 7, GEORGIA RAPTOU 2, SOFIA CHRISAFI 3, EPAMINONTAS SAMANTAS 8, KLEO PAPAPARASKEVA 9, ELISSAVET PAZARLI 10 , PAVLOS PAPAKOSTAS 11 , GEORGIA KAFIRI 12 , DAVIDE MAURI 13 , ALEXANDRA PAPOUDOU-BAI 14 , CHRISTOS CHRISTODOULOU 15 , KALLIOPI PETRAKI 16 , NIKOLAOS DOMBROS 17 , DIMITRIOS PECTASIDES 18 and GEORGE FOUNTZILAS 5,17 1Department of Medical Oncology, School of Health Sciences, Faculty of Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece; 2Department of Pathology, School of Health Sciences, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece; 3Asklepios Oncology Department, Heraklion, Greece; 4Section of Biostatistics, Hellenic Cooperative Oncology Group, Data Office, Athens, Greece; 5Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, Thessaloniki, Greece; 6Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Patras, Greece; 7Department of Pathology, University Hospital of Patras, Patras, Greece; 8Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, Athens, Greece; 9Department of Pathology,
    [Show full text]
  • Coronary Arterial Development Is Regulated by a Dll4-Jag1-Ephrinb2 Signaling Cascade
    RESEARCH ARTICLE Coronary arterial development is regulated by a Dll4-Jag1-EphrinB2 signaling cascade Stanislao Igor Travisano1,2, Vera Lucia Oliveira1,2, Bele´ n Prados1,2, Joaquim Grego-Bessa1,2, Rebeca Pin˜ eiro-Sabarı´s1,2, Vanesa Bou1,2, Manuel J Go´ mez3, Fa´ tima Sa´ nchez-Cabo3, Donal MacGrogan1,2*, Jose´ Luis de la Pompa1,2* 1Intercellular Signalling in Cardiovascular Development and Disease Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain; 2CIBER de Enfermedades Cardiovasculares, Madrid, Spain; 3Bioinformatics Unit, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain Abstract Coronaries are essential for myocardial growth and heart function. Notch is crucial for mouse embryonic angiogenesis, but its role in coronary development remains uncertain. We show Jag1, Dll4 and activated Notch1 receptor expression in sinus venosus (SV) endocardium. Endocardial Jag1 removal blocks SV capillary sprouting, while Dll4 inactivation stimulates excessive capillary growth, suggesting that ligand antagonism regulates coronary primary plexus formation. Later endothelial ligand removal, or forced expression of Dll4 or the glycosyltransferase Mfng, blocks coronary plexus remodeling, arterial differentiation, and perivascular cell maturation. Endocardial deletion of Efnb2 phenocopies the coronary arterial defects of Notch mutants. Angiogenic rescue experiments in ventricular explants, or in primary human endothelial cells, indicate that EphrinB2 is a critical effector of antagonistic Dll4 and Jag1 functions in arterial morphogenesis. Thus, coronary arterial precursors are specified in the SV prior to primary coronary plexus formation and subsequent arterial differentiation depends on a Dll4-Jag1-EphrinB2 signaling *For correspondence: [email protected] (DMG); cascade. [email protected] (JLP) Competing interests: The authors declare that no Introduction competing interests exist.
    [Show full text]
  • Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms
    Journal of Clinical Medicine Review Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms 1,2, 1, 3, 4 Claudia von Arx y , Monica Capozzi y, Elena López-Jiménez y, Alessandro Ottaiano , Fabiana Tatangelo 5 , Annabella Di Mauro 5, Guglielmo Nasti 4, Maria Lina Tornesello 6,* and Salvatore Tafuto 1,* On behalf of ENETs (European NeuroEndocrine Tumor Society) Center of Excellence of Naples, Italy 1 Department of Abdominal Oncology, Istituto Nazionale Tumori, IRCCS Fondazione “G. Pascale”, 80131 Naples, Italy 2 Department of Surgery and Cancer, Imperial College London, London W12 0HS, UK 3 Cancer Cell Metabolism Group. Centre for Haematology, Immunology and Inflammation Department, Imperial College London, London W12 0HS, UK 4 SSD Innovative Therapies for Abdominal Metastases—Department of Abdominal Oncology, Istituto Nazionale Tumori, IRCCS—Fondazione “G. Pascale”, 80131 Naples, Italy 5 Department of Pathology, Istituto Nazionale Tumori, IRCCS—Fondazione “G. Pascale”, 80131 Naples, Italy 6 Unit of Molecular Biology and Viral Oncology, Department of Research, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Naples, Italy * Correspondence: [email protected] (M.L.T.); [email protected] (S.T.) These authors contributed to this paper equally. y Received: 10 July 2019; Accepted: 20 August 2019; Published: 22 August 2019 Abstract: Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of rare malignancies, mainly originating from hormone-secreting cells, which are widespread in human tissues. The identification of mutations in ATRX/DAXX genes in sporadic NENs, as well as the high burden of mutations scattered throughout the multiple endocrine neoplasia type 1 (MEN-1) gene in both sporadic and inherited syndromes, provided new insights into the molecular biology of tumour development.
    [Show full text]
  • NOTCH3 Gene Notch 3
    NOTCH3 gene notch 3 Normal Function The NOTCH3 gene provides instructions for making a protein with one end (the intracellular end) that remains inside the cell, a middle (transmembrane) section that spans the cell membrane, and another end (the extracellular end) that projects from the outer surface of the cell. The NOTCH3 protein is called a receptor protein because certain other proteins, called ligands, attach (bind) to the extracellular end of NOTCH3, fitting like a key into a lock. This binding causes detachment of the intracellular end of the NOTCH3 protein, called the NOTCH3 intracellular domain, or NICD. The NICD enters the cell nucleus and helps control the activity (transcription) of other genes. The NOTCH3 protein plays a key role in the function and survival of vascular smooth muscle cells, which are muscle cells that surround blood vessels. This protein is thought to be essential for the maintenance of blood vessels, including those that supply blood to the brain. Health Conditions Related to Genetic Changes Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy More than 270 mutations in the NOTCH3 gene have been found to cause cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, commonly known as CADASIL. Almost all of these mutations change a single protein building block (amino acid) in the NOTCH3 protein. The amino acid involved in most mutations is cysteine. The addition or deletion of a cysteine molecule in a certain area of the NOTCH3 protein, known as the EGF-like domain, presumably affects NOTCH3 function in vascular smooth muscle cells. Disruption of NOTCH3 functioning can lead to the self-destruction (apoptosis) of these cells.
    [Show full text]
  • It's T-ALL About Notch
    Oncogene (2008) 27, 5082–5091 & 2008 Macmillan Publishers Limited All rights reserved 0950-9232/08 $30.00 www.nature.com/onc REVIEW It’s T-ALL about Notch RM Demarest1, F Ratti1 and AJ Capobianco Molecular and Cellular Oncogenesis, The Wistar Institute, Philadelphia, PA, USA T-cell acute lymphoblastic leukemia (T-ALL) is an about T-ALL make it a more aggressive disease with a aggressive subset ofALL with poor clinical outcome poorer clinical outcome than B-ALL. T-ALL patients compared to B-ALL. Therefore, to improve treatment, it have a higher percentage of induction failure, and rate is imperative to delineate the molecular blueprint ofthis of relapse and invasion into the central nervous system disease. This review describes the central role that the (reviewed in Aifantis et al., 2008). The challenge to Notch pathway plays in T-ALL development. We also acquiring 100% remission in T-ALL treatment is the discuss the interactions between Notch and the tumor subset of patients (20–25%) whose disease is refractory suppressors Ikaros and p53. Loss ofIkaros, a direct to initial treatments or relapses after a short remission repressor ofNotch target genes, and suppression ofp53- period due to drug resistance. Therefore, it is imperative mediated apoptosis are essential for development of this to delineate the molecular blueprint that collectively neoplasm. In addition to the activating mutations of accounts for the variety of subtypes in T-ALL. This will Notch previously described, this review will outline allow for the development of targeted therapies that combinations ofmutations in pathways that contribute inhibit T-ALL growth by disrupting the critical path- to Notch signaling and appear to drive T-ALL develop- ways responsible for the neoplasm.
    [Show full text]
  • Repressor Activity in Notch 3 3927
    Development 126, 3925-3935 (1999) 3925 Printed in Great Britain © The Company of Biologists Limited 1999 DEV9635 The Notch 3 intracellular domain represses Notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters Paul Beatus, Johan Lundkvist, Camilla Öberg and Urban Lendahl* Department of Cell and Molecular Biology, Medical Nobel Institute, Karolinska Institute, S-171 77 Stockholm, Sweden *Author for correspondence (e-mail: [email protected]) Accepted 9 June; published on WWW 5 August 1999 SUMMARY The Notch signaling pathway is important for cellular levels. First, Notch 3 IC competes with Notch 1 IC for differentiation. The current view is that the Notch receptor access to RBP-Jk and does not activate transcription when is cleaved intracellularly upon ligand activation. The positioned close to a promoter. Second, Notch 3 IC appears intracellular Notch domain then translocates to the to compete with Notch 1 IC for a common coactivator nucleus, binds to Suppressor of Hairless (RBP-Jk in present in limiting amounts. In conclusion, this is the first mammals), and acts as a transactivator of Enhancer of Split example of a Notch IC that functions as a repressor in (HES in mammals) gene expression. In this report we show Enhancer of Split/HES upregulation, and shows that that the Notch 3 intracellular domain (IC), in contrast to mammalian Notch receptors have acquired distinct all other analysed Notch ICs, is a poor activator, and in fact functions during evolution. acts as a repressor by blocking the ability of the Notch 1 IC to activate expression through the HES-1 and HES-5 promoters.
    [Show full text]
  • Coactivation of NF-Kb and Notch Signaling Is Sufficient to Induce B
    Regular Article LYMPHOID NEOPLASIA Coactivation of NF-kB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion Downloaded from https://ashpublications.org/blood/article-pdf/135/2/108/1550992/bloodbld2019001438.pdf by UNIV OF IOWA LIBRARIES user on 20 February 2020 Yan Xiu,1,* Qianze Dong,1,2,* Lin Fu,1,2 Aaron Bossler,1 Xiaobing Tang,1,2 Brendan Boyce,3 Nicholas Borcherding,1 Mariah Leidinger,1 Jose´ Luis Sardina,4,5 Hai-hui Xue,6 Qingchang Li,2 Andrew Feldman,7 Iannis Aifantis,8 Francesco Boccalatte,8 Lili Wang,9 Meiling Jin,9 Joseph Khoury,10 Wei Wang,10 Shimin Hu,10 Youzhong Yuan,11 Endi Wang,12 Ji Yuan,13 Siegfried Janz,14 John Colgan,15 Hasem Habelhah,1 Thomas Waldschmidt,1 Markus Muschen,¨ 9 Adam Bagg,16 Benjamin Darbro,17 and Chen Zhao1,18 1Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA; 2Department of Pathology, China Medical University, Shenyang, China; 3Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY; 4Gene Regulation, Stem Cells and Cancer Program, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain; 5Josep Carreras Leukaemia Research Institute, Campus ICO-Germans Trias i Pujol, Barcelona, Spain; 6Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, IA; 7Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN; 8Department of Pathology, NYU School of Medicine,
    [Show full text]
  • Off the Beaten Pathway: the Complex Cross Talk Between Notch and NF-Kb Clodia Osipo1,2, Todd E Golde3, Barbara a Osborne4 and Lucio a Miele1,2,5
    Laboratory Investigation (2008) 88, 11–17 & 2008 USCAP, Inc All rights reserved 0023-6837/08 $30.00 PATHOBIOLOGY IN FOCUS Off the beaten pathway: the complex cross talk between Notch and NF-kB Clodia Osipo1,2, Todd E Golde3, Barbara A Osborne4 and Lucio A Miele1,2,5 The canonical Notch pathway that has been well characterized over the past 25 years is relatively simple compared to the plethora of recently published data suggesting non-canonical signaling mechanisms and cross talk with other pathways. The manner in which other pathways cross talk with Notch signaling appears to be extraordinarily complex and, not surprisingly, context-dependent. While the physiological relevance of many of these interactions remains to be estab- lished, there is little doubt that Notch signaling is integrated with numerous other pathways in ways that appear increasingly complex. Among the most intricate cross talks described for Notch is its interaction with the NF-kB pathway, another major cell fate regulatory network involved in development, immunity, and cancer. Numerous reports over the last 11 years have described multiple cross talk mechanisms between Notch and NF-kB in diverse experimental models. This article will provide a brief overview of the published evidence for Notch–NF-kB cross talk, focusing on vertebrate systems. Laboratory Investigation (2008) 88, 11–17; doi:10.1038/labinvest.3700700; published online 3 December 2007 KEYWORDS: Notch signaling; NF-kB cross talk; non-canonical signaling; IKK kinases CANONICAL NOTCH SIGNALING endocytosed into the ligand-expressing cell.10 This unmasks Canonical Notch signaling has been recently reviewed by the HD and triggers an extracellular cleavage in it by ADAM several authors,1–6 and the reader is referred to these reviews (a disintegrin and metalloproteinase) 10 or 17,1,2 followed by for detailed information and additional references.
    [Show full text]
  • Notch 2 (M-20): Sc-7423
    SAN TA C RUZ BI OTEC HNOL OG Y, INC . Notch 2 (M-20): sc-7423 BACKGROUND SELECT PRODUCT CITATIONS The LIN-12/Notch family of transmembrane receptors is believed to play a 1. Nijjar, S.S., et al. 2002. Altered Notch ligand expression in human liver central role in development by regulating cell fate decisions. To date, four disease: further evidence for a role of the Notch signaling pathway in notch homologs have been identified in mammals and have been designated hepatic neovascularization and biliary ductular defects. Am. J. Pathol. 160: Notch 1, Notch 2, Notch 3 and Notch 4. The notch genes are expressed in a 1695-1703. variety of tissues in both the embryonic and adult organism, suggesting that 2. Tsunematsu, R., et al. 2004. Mouse Fbw7/SEL-10/Cdc4 is required for the genes are involved in multiple signaling pathways. The notch proteins Notch degradation during vascular development. J. Biol. Chem. 279: have been found to be overexpressed or rearranged in human tumors. Ligands 9417-9423. for notch include Jagged1, Jagged2 and Delta. Jagged can activate notch and prevent myoblast differentiation by inhibiting the expression of muscle 3. Parr, C., et al. 2004. The possible correlation of Notch receptors, Notch 1 regulatory and structural genes. Jagged2 is thought to be involved in the and Notch 2, with clinical outcome and tumour clinicopathological development of various tissues whose development is dependent upon epithe - para- meters in human breast cancers. Int. J. Mol. Med. 14: 779-786. lial-mesenchymal interactions. Normal Delta expression is restricted to the 4.
    [Show full text]
  • Notch Signaling: Simplicity in Design, Versatility in Function Emma R
    REVIEW 3593 Development 138, 3593-3612 (2011) doi:10.1242/dev.063610 © 2011. Published by The Company of Biologists Ltd Notch signaling: simplicity in design, versatility in function Emma R. Andersson1, Rickard Sandberg2 and Urban Lendahl1,* Summary different cell types and organs have recently been reviewed (Liu et Notch signaling is evolutionarily conserved and operates in al., 2010) and are summarized in Table 1. In keeping with its many cell types and at various stages during development. important role in many cell types, the mutation of Notch genes Notch signaling must therefore be able to generate leads to diseases in various organs and tissues (Table 2). These appropriate signaling outputs in a variety of cellular contexts. studies highlight the fact that the Notch pathway must be able to This need for versatility in Notch signaling is in apparent elicit appropriate responses in many spatially and temporally contrast to the simple molecular design of the core pathway. distinct cell contexts. Here, we review recent studies in nematodes, Drosophila and In this review, we address the conundrum of how this functional vertebrate systems that begin to shed light on how versatility diversity is compatible with the simplistic molecular design of the in Notch signaling output is generated, how signal strength is Notch signaling pathway. In particular, we focus on recent modulated, and how cross-talk between the Notch pathway observations, in both vertebrate and invertebrate systems, that and other intracellular signaling systems, such as the Wnt, begin to shed light on how diversity is generated at different steps hypoxia and BMP pathways, contributes to signaling diversity.
    [Show full text]
  • NOTCH1 Gene Notch 1
    NOTCH1 gene notch 1 Normal Function The NOTCH1 gene provides instructions for making a protein called Notch1, a member of the Notch family of receptors. Receptor proteins have specific sites into which certain other proteins, called ligands, fit like keys into locks. Attachment of a ligand to the Notch1 receptor sends signals that are important for normal development of many tissues throughout the body, both before birth and after. Notch1 signaling helps determine the specialization of cells into certain cell types that perform particular functions in the body (cell fate determination). It also plays a role in cell growth and division (proliferation), maturation (differentiation), and self-destruction (apoptosis). The protein produced from the NOTCH1 gene has such diverse functions that the gene is considered both an oncogene and a tumor suppressor. Oncogenes typically promote cell proliferation or survival, and when mutated, they have the potential to cause normal cells to become cancerous. In contrast, tumor suppressors keep cells from growing and dividing too fast or in an uncontrolled way, preventing the development of cancer; mutations that impair tumor suppressors can lead to cancer development. Health Conditions Related to Genetic Changes Adams-Oliver syndrome At least 15 mutations in the NOTCH1 gene have been found to cause Adams-Oliver syndrome, a condition characterized by areas of missing skin (aplasia cutis congenita), usually on the scalp, and malformations of the hands and feet. These mutations are usually inherited and are present in every cell of the body. Some of the NOTCH1 gene mutations involved in Adams-Oliver syndrome lead to production of an abnormally short protein that is likely broken down quickly, causing a shortage of Notch1.
    [Show full text]
  • Notch Signaling in Breast Cancer: a Role in Drug Resistance
    cells Review Notch Signaling in Breast Cancer: A Role in Drug Resistance McKenna BeLow 1 and Clodia Osipo 1,2,3,* 1 Integrated Cell Biology Program, Loyola University Chicago, Maywood, IL 60513, USA; [email protected] 2 Department of Cancer Biology, Loyola University Chicago, Maywood, IL 60513, USA 3 Department of Microbiology and Immunology, Loyola University Chicago, Maywood, IL 60513, USA * Correspondence: [email protected]; Tel.: +1-708-327-2372 Received: 12 September 2020; Accepted: 28 September 2020; Published: 29 September 2020 Abstract: Breast cancer is a heterogeneous disease that can be subdivided into unique molecular subtypes based on protein expression of the Estrogen Receptor, Progesterone Receptor, and/or the Human Epidermal Growth Factor Receptor 2. Therapeutic approaches are designed to inhibit these overexpressed receptors either by endocrine therapy, targeted therapies, or combinations with cytotoxic chemotherapy. However, a significant percentage of breast cancers are inherently resistant or acquire resistance to therapies, and mechanisms that promote resistance remain poorly understood. Notch signaling is an evolutionarily conserved signaling pathway that regulates cell fate, including survival and self-renewal of stem cells, proliferation, or differentiation. Deregulation of Notch signaling promotes resistance to targeted or cytotoxic therapies by enriching of a small population of resistant cells, referred to as breast cancer stem cells, within the bulk tumor; enhancing stem-like features during the process of de-differentiation of tumor cells; or promoting epithelial to mesenchymal transition. Preclinical studies have shown that targeting the Notch pathway can prevent or reverse resistance through reduction or elimination of breast cancer stem cells. However, Notch inhibitors have yet to be clinically approved for the treatment of breast cancer, mainly due to dose-limiting gastrointestinal toxicity.
    [Show full text]